nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—CYP2C8—Acetylsalicylic acid—Kawasaki disease	0.196	0.596	CbGbCtD
Ponatinib—ABCB1—Acetylsalicylic acid—Kawasaki disease	0.133	0.404	CbGbCtD
Ponatinib—Nilotinib—BLK—Kawasaki disease	0.0218	1	CrCbGaD
Ponatinib—KDR—umbilical vein—Kawasaki disease	0.0195	0.0632	CbGeAlD
Ponatinib—TEK—artery—Kawasaki disease	0.0134	0.0434	CbGeAlD
Ponatinib—SRC—artery—Kawasaki disease	0.0119	0.0386	CbGeAlD
Ponatinib—FGFR4—heart—Kawasaki disease	0.0115	0.0373	CbGeAlD
Ponatinib—TEK—endothelium—Kawasaki disease	0.0113	0.0367	CbGeAlD
Ponatinib—KDR—artery—Kawasaki disease	0.0109	0.0355	CbGeAlD
Ponatinib—BCR—cardiac ventricle—Kawasaki disease	0.0103	0.0336	CbGeAlD
Ponatinib—SRC—endothelium—Kawasaki disease	0.01	0.0326	CbGeAlD
Ponatinib—BCR—myocardium—Kawasaki disease	0.00972	0.0316	CbGeAlD
Ponatinib—KDR—endothelium—Kawasaki disease	0.00923	0.03	CbGeAlD
Ponatinib—PDGFRA—gall bladder—Kawasaki disease	0.00887	0.0288	CbGeAlD
Ponatinib—FGFR1—myocardium—Kawasaki disease	0.00865	0.0281	CbGeAlD
Ponatinib—KIT—endothelium—Kawasaki disease	0.00818	0.0266	CbGeAlD
Ponatinib—RET—neck—Kawasaki disease	0.00817	0.0266	CbGeAlD
Ponatinib—FGFR3—heart—Kawasaki disease	0.00784	0.0255	CbGeAlD
Ponatinib—FGFR2—neck—Kawasaki disease	0.00777	0.0252	CbGeAlD
Ponatinib—FGFR3—skin of body—Kawasaki disease	0.00768	0.025	CbGeAlD
Ponatinib—TEK—cardiac ventricle—Kawasaki disease	0.0075	0.0244	CbGeAlD
Ponatinib—KIT—gall bladder—Kawasaki disease	0.00709	0.0231	CbGeAlD
Ponatinib—TEK—myocardium—Kawasaki disease	0.00705	0.0229	CbGeAlD
Ponatinib—BCR—heart—Kawasaki disease	0.00679	0.0221	CbGeAlD
Ponatinib—FLT3—heart—Kawasaki disease	0.00674	0.0219	CbGeAlD
Ponatinib—KDR—cardiac ventricle—Kawasaki disease	0.00613	0.0199	CbGeAlD
Ponatinib—KDR—neck—Kawasaki disease	0.00609	0.0198	CbGeAlD
Ponatinib—FGFR1—heart—Kawasaki disease	0.00604	0.0196	CbGeAlD
Ponatinib—KDR—myocardium—Kawasaki disease	0.00576	0.0187	CbGeAlD
Ponatinib—RET—heart—Kawasaki disease	0.0054	0.0176	CbGeAlD
Ponatinib—LCK—heart—Kawasaki disease	0.0054	0.0176	CbGeAlD
Ponatinib—KIT—neck—Kawasaki disease	0.00539	0.0175	CbGeAlD
Ponatinib—KIT—myocardium—Kawasaki disease	0.00511	0.0166	CbGeAlD
Ponatinib—FGFR2—skin of body—Kawasaki disease	0.00503	0.0163	CbGeAlD
Ponatinib—TEK—heart—Kawasaki disease	0.00492	0.016	CbGeAlD
Ponatinib—ABL1—cardiac ventricle—Kawasaki disease	0.00473	0.0154	CbGeAlD
Ponatinib—PDGFRA—heart—Kawasaki disease	0.00446	0.0145	CbGeAlD
Ponatinib—ABL1—myocardium—Kawasaki disease	0.00445	0.0144	CbGeAlD
Ponatinib—SRC—heart—Kawasaki disease	0.00437	0.0142	CbGeAlD
Ponatinib—SRC—skin of body—Kawasaki disease	0.00428	0.0139	CbGeAlD
Ponatinib—KDR—heart—Kawasaki disease	0.00402	0.0131	CbGeAlD
Ponatinib—KIT—heart—Kawasaki disease	0.00356	0.0116	CbGeAlD
Ponatinib—KIT—skin of body—Kawasaki disease	0.00349	0.0113	CbGeAlD
Ponatinib—ABL1—heart—Kawasaki disease	0.0031	0.0101	CbGeAlD
Ponatinib—ABL1—skin of body—Kawasaki disease	0.00304	0.00987	CbGeAlD
Ponatinib—ABCG2—heart—Kawasaki disease	0.00196	0.00636	CbGeAlD
Ponatinib—ABCB1—heart—Kawasaki disease	0.000965	0.00314	CbGeAlD
Ponatinib—KDR—EPH-Ephrin signaling—VEGFA—Kawasaki disease	0.000723	0.00212	CbGpPWpGaD
Ponatinib—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—Kawasaki disease	0.000721	0.00211	CbGpPWpGaD
Ponatinib—LCK—TCR signaling—CD4—Kawasaki disease	0.000712	0.00209	CbGpPWpGaD
Ponatinib—LYN—LPA receptor mediated events—MMP9—Kawasaki disease	0.000709	0.00208	CbGpPWpGaD
Ponatinib—FGFR3—Innate Immune System—FCGR2A—Kawasaki disease	0.000709	0.00207	CbGpPWpGaD
Ponatinib—LCK—IL12-mediated signaling events—CD4—Kawasaki disease	0.000703	0.00206	CbGpPWpGaD
Ponatinib—SRC—Focal Adhesion—BLK—Kawasaki disease	0.000684	0.002	CbGpPWpGaD
Ponatinib—ABCB1—Allograft Rejection—CD40—Kawasaki disease	0.000679	0.00199	CbGpPWpGaD
Ponatinib—SRC—Signaling events mediated by TCPTP—VEGFA—Kawasaki disease	0.000673	0.00197	CbGpPWpGaD
Ponatinib—FGFR3—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.000668	0.00196	CbGpPWpGaD
Ponatinib—FGFR3—Adaptive Immune System—BLK—Kawasaki disease	0.00066	0.00193	CbGpPWpGaD
Ponatinib—LYN—CXCR4-mediated signaling events—CD4—Kawasaki disease	0.000655	0.00192	CbGpPWpGaD
Ponatinib—KDR—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.000652	0.00191	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—ITPKC—Kawasaki disease	0.000651	0.00191	CbGpPWpGaD
Ponatinib—LCK—TCR signaling in naïve CD4+ T cells—CD4—Kawasaki disease	0.000651	0.00191	CbGpPWpGaD
Ponatinib—SRC—EPH-ephrin mediated repulsion of cells—MMP9—Kawasaki disease	0.000648	0.0019	CbGpPWpGaD
Ponatinib—LCK—Costimulation by the CD28 family—CD4—Kawasaki disease	0.000636	0.00186	CbGpPWpGaD
Ponatinib—KDR—Signaling by VEGF—VEGFA—Kawasaki disease	0.000615	0.0018	CbGpPWpGaD
Ponatinib—PDGFRA—Allograft Rejection—VEGFA—Kawasaki disease	0.00061	0.00179	CbGpPWpGaD
Ponatinib—SRC—Aryl Hydrocarbon Receptor—VEGFA—Kawasaki disease	0.000602	0.00176	CbGpPWpGaD
Ponatinib—SRC—FGF signaling pathway—MMP9—Kawasaki disease	0.00059	0.00173	CbGpPWpGaD
Ponatinib—LYN—CXCR4-mediated signaling events—MMP9—Kawasaki disease	0.000571	0.00167	CbGpPWpGaD
Ponatinib—LCK—SHP2 signaling—VEGFA—Kawasaki disease	0.000565	0.00165	CbGpPWpGaD
Ponatinib—SRC—Costimulation by the CD28 family—CD4—Kawasaki disease	0.000563	0.00165	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—FCGR2A—Kawasaki disease	0.000558	0.00163	CbGpPWpGaD
Ponatinib—FGFR3—Adaptive Immune System—CD40—Kawasaki disease	0.000549	0.00161	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—BLK—Kawasaki disease	0.000541	0.00158	CbGpPWpGaD
Ponatinib—LCK—CXCR4-mediated signaling events—CD4—Kawasaki disease	0.000537	0.00157	CbGpPWpGaD
Ponatinib—LYN—EPH-Ephrin signaling—MMP9—Kawasaki disease	0.000521	0.00153	CbGpPWpGaD
Ponatinib—ABCB1—Allograft Rejection—IL10—Kawasaki disease	0.00052	0.00152	CbGpPWpGaD
Ponatinib—SRC—LPA receptor mediated events—MMP9—Kawasaki disease	0.000515	0.00151	CbGpPWpGaD
Ponatinib—SRC—AGE/RAGE pathway—MMP9—Kawasaki disease	0.000502	0.00147	CbGpPWpGaD
Ponatinib—FGFR4—Innate Immune System—CRP—Kawasaki disease	0.000498	0.00146	CbGpPWpGaD
Ponatinib—ABCG2—HIF-1-alpha transcription factor network—VEGFA—Kawasaki disease	0.000493	0.00144	CbGpPWpGaD
Ponatinib—FGFR2—Innate Immune System—FCGR2A—Kawasaki disease	0.000487	0.00143	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—FCGR2A—Kawasaki disease	0.000479	0.0014	CbGpPWpGaD
Ponatinib—SRC—CXCR4-mediated signaling events—CD4—Kawasaki disease	0.000475	0.00139	CbGpPWpGaD
Ponatinib—LYN—EPH-Ephrin signaling—VEGFA—Kawasaki disease	0.000468	0.00137	CbGpPWpGaD
Ponatinib—SRC—Integrins in angiogenesis—VEGFA—Kawasaki disease	0.000468	0.00137	CbGpPWpGaD
Ponatinib—LCK—CXCR4-mediated signaling events—MMP9—Kawasaki disease	0.000468	0.00137	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.00046	0.00135	CbGpPWpGaD
Ponatinib—SRC—Oncostatin M Signaling Pathway—VEGFA—Kawasaki disease	0.000456	0.00134	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—FCGR2A—Kawasaki disease	0.000454	0.00133	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—BLK—Kawasaki disease	0.000454	0.00133	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—FCGR2A—Kawasaki disease	0.000453	0.00133	CbGpPWpGaD
Ponatinib—KIT—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.000452	0.00132	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—CD40—Kawasaki disease	0.00045	0.00132	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—BLK—Kawasaki disease	0.000446	0.0013	CbGpPWpGaD
Ponatinib—SRC—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	0.00044	0.00129	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—ITPKC—Kawasaki disease	0.000431	0.00126	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.000428	0.00125	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.000427	0.00125	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—BLK—Kawasaki disease	0.000423	0.00124	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—BLK—Kawasaki disease	0.000422	0.00124	CbGpPWpGaD
Ponatinib—SRC—CXCR4-mediated signaling events—MMP9—Kawasaki disease	0.000414	0.00121	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—FCGR2A—Kawasaki disease	0.000413	0.00121	CbGpPWpGaD
Ponatinib—KDR—Focal Adhesion—VEGFA—Kawasaki disease	0.000412	0.00121	CbGpPWpGaD
Ponatinib—BCR—Disease—CCR5—Kawasaki disease	0.000409	0.0012	CbGpPWpGaD
Ponatinib—LCK—HIV Infection—CCR5—Kawasaki disease	0.000402	0.00118	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—BLK—Kawasaki disease	0.0004	0.00117	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—FCGR2A—Kawasaki disease	0.0004	0.00117	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—FCGR2A—Kawasaki disease	0.000398	0.00116	CbGpPWpGaD
Ponatinib—LCK—Host Interactions of HIV factors—CD4—Kawasaki disease	0.000388	0.00114	CbGpPWpGaD
Ponatinib—SRC—EPH-Ephrin signaling—MMP9—Kawasaki disease	0.000378	0.00111	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—CD40—Kawasaki disease	0.000377	0.0011	CbGpPWpGaD
Ponatinib—LYN—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.000377	0.0011	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—BLK—Kawasaki disease	0.000372	0.00109	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—CD40—Kawasaki disease	0.000371	0.00108	CbGpPWpGaD
Ponatinib—FGFR3—Innate Immune System—CRP—Kawasaki disease	0.000368	0.00108	CbGpPWpGaD
Ponatinib—KDR—Extracellular matrix organization—MMP9—Kawasaki disease	0.000353	0.00103	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—CD40—Kawasaki disease	0.000352	0.00103	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—CD40—Kawasaki disease	0.000351	0.00103	CbGpPWpGaD
Ponatinib—SRC—EPH-Ephrin signaling—VEGFA—Kawasaki disease	0.00034	0.000994	CbGpPWpGaD
Ponatinib—FGFR4—Innate Immune System—CD4—Kawasaki disease	0.000336	0.000984	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—CD40—Kawasaki disease	0.000333	0.000974	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—FCGR2A—Kawasaki disease	0.000328	0.000959	CbGpPWpGaD
Ponatinib—FGFR4—Adaptive Immune System—CD4—Kawasaki disease	0.000323	0.000945	CbGpPWpGaD
Ponatinib—ABL1—Integrated Breast Cancer Pathway—VEGFA—Kawasaki disease	0.000319	0.000934	CbGpPWpGaD
Ponatinib—TEK—Hemostasis—VEGFA—Kawasaki disease	0.000314	0.000919	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—CD40—Kawasaki disease	0.000309	0.000905	CbGpPWpGaD
Ponatinib—LCK—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.000309	0.000904	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ITPKC—Kawasaki disease	0.000308	0.000903	CbGpPWpGaD
Ponatinib—SRC—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.000306	0.000896	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—BLK—Kawasaki disease	0.000305	0.000893	CbGpPWpGaD
Ponatinib—PDGFRA—Focal Adhesion—VEGFA—Kawasaki disease	0.000302	0.000885	CbGpPWpGaD
Ponatinib—FGFR1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	0.000302	0.000883	CbGpPWpGaD
Ponatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	0.000301	0.000881	CbGpPWpGaD
Ponatinib—KDR—Axon guidance—MMP9—Kawasaki disease	0.000299	0.000876	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—FCGR2A—Kawasaki disease	0.00029	0.000849	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—CRP—Kawasaki disease	0.00029	0.000848	CbGpPWpGaD
Ponatinib—SRC—Signaling by VEGF—VEGFA—Kawasaki disease	0.000289	0.000846	CbGpPWpGaD
Ponatinib—FGFR4—Disease—CCR5—Kawasaki disease	0.000288	0.000842	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—CCR5—Kawasaki disease	0.000286	0.000837	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—FCGR2A—Kawasaki disease	0.000284	0.000831	CbGpPWpGaD
Ponatinib—KIT—Immune System—FCGR2A—Kawasaki disease	0.000279	0.000816	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—BLK—Kawasaki disease	0.000275	0.000806	CbGpPWpGaD
Ponatinib—SRC—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.000274	0.000801	CbGpPWpGaD
Ponatinib—KIT—Immune System—BLK—Kawasaki disease	0.00027	0.000791	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—BLK—Kawasaki disease	0.00027	0.000791	CbGpPWpGaD
Ponatinib—KDR—Axon guidance—VEGFA—Kawasaki disease	0.000269	0.000787	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ITPKC—Kawasaki disease	0.000267	0.000782	CbGpPWpGaD
Ponatinib—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Kawasaki disease	0.000267	0.000781	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—FCGR2A—Kawasaki disease	0.000265	0.000774	CbGpPWpGaD
Ponatinib—ABL1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	0.000264	0.000774	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—FCGR2A—Kawasaki disease	0.000264	0.000772	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—BLK—Kawasaki disease	0.000257	0.000751	CbGpPWpGaD
Ponatinib—BCR—Disease—CD4—Kawasaki disease	0.000257	0.000751	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—BLK—Kawasaki disease	0.000256	0.000749	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—CD40—Kawasaki disease	0.000254	0.000742	CbGpPWpGaD
Ponatinib—FGFR2—Innate Immune System—CRP—Kawasaki disease	0.000253	0.000741	CbGpPWpGaD
Ponatinib—LCK—HIV Infection—CD4—Kawasaki disease	0.000252	0.000738	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—CRP—Kawasaki disease	0.000249	0.000728	CbGpPWpGaD
Ponatinib—FGFR3—Innate Immune System—CD4—Kawasaki disease	0.000249	0.000728	CbGpPWpGaD
Ponatinib—FGFR3—Adaptive Immune System—CD4—Kawasaki disease	0.000239	0.000699	CbGpPWpGaD
Ponatinib—LYN—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	0.000236	0.000692	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—CRP—Kawasaki disease	0.000236	0.000691	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—CRP—Kawasaki disease	0.000235	0.000689	CbGpPWpGaD
Ponatinib—LYN—Immune System—FCGR2A—Kawasaki disease	0.000233	0.000681	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ITPKC—Kawasaki disease	0.000233	0.000681	CbGpPWpGaD
Ponatinib—ABL1—Immune System—FCGR2A—Kawasaki disease	0.000232	0.000678	CbGpPWpGaD
Ponatinib—ABCB1—Allograft Rejection—VEGFA—Kawasaki disease	0.000231	0.000676	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CD40—Kawasaki disease	0.000229	0.00067	CbGpPWpGaD
Ponatinib—LYN—Immune System—BLK—Kawasaki disease	0.000226	0.000661	CbGpPWpGaD
Ponatinib—KIT—Immune System—CD40—Kawasaki disease	0.000225	0.000658	CbGpPWpGaD
Ponatinib—ABL1—Immune System—BLK—Kawasaki disease	0.000225	0.000658	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—CD40—Kawasaki disease	0.000224	0.000657	CbGpPWpGaD
Ponatinib—FGFR1—Axon guidance—MMP9—Kawasaki disease	0.00022	0.000645	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ITPKC—Kawasaki disease	0.000219	0.000642	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—CRP—Kawasaki disease	0.000214	0.000627	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—MMP9—Kawasaki disease	0.000214	0.000625	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CD40—Kawasaki disease	0.000213	0.000624	CbGpPWpGaD
Ponatinib—FGFR3—Disease—CCR5—Kawasaki disease	0.000213	0.000623	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CD40—Kawasaki disease	0.000213	0.000623	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—CRP—Kawasaki disease	0.000208	0.000608	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—CRP—Kawasaki disease	0.000207	0.000605	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—CCR5—Kawasaki disease	0.000202	0.00059	CbGpPWpGaD
Ponatinib—FGFR1—Axon guidance—VEGFA—Kawasaki disease	0.000198	0.000579	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—CD4—Kawasaki disease	0.000196	0.000573	CbGpPWpGaD
Ponatinib—LYN—Axon guidance—MMP9—Kawasaki disease	0.000194	0.000567	CbGpPWpGaD
Ponatinib—LCK—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	0.000194	0.000567	CbGpPWpGaD
Ponatinib—SRC—Focal Adhesion—VEGFA—Kawasaki disease	0.000193	0.000566	CbGpPWpGaD
Ponatinib—ABL1—Axon guidance—MMP9—Kawasaki disease	0.000193	0.000564	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	0.000193	0.000564	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—VEGFA—Kawasaki disease	0.000192	0.000561	CbGpPWpGaD
Ponatinib—LCK—Immune System—FCGR2A—Kawasaki disease	0.000191	0.000558	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD40—Kawasaki disease	0.000188	0.000549	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD40—Kawasaki disease	0.000187	0.000547	CbGpPWpGaD
Ponatinib—LCK—Immune System—BLK—Kawasaki disease	0.000185	0.000542	CbGpPWpGaD
Ponatinib—FGFR4—Disease—CD4—Kawasaki disease	0.000181	0.000529	CbGpPWpGaD
Ponatinib—LYN—Axon guidance—VEGFA—Kawasaki disease	0.000174	0.000509	CbGpPWpGaD
Ponatinib—ABL1—Axon guidance—VEGFA—Kawasaki disease	0.000173	0.000507	CbGpPWpGaD
Ponatinib—SRC—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	0.000171	0.000502	CbGpPWpGaD
Ponatinib—FGFR2—Innate Immune System—CD4—Kawasaki disease	0.000171	0.000501	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—CRP—Kawasaki disease	0.00017	0.000498	CbGpPWpGaD
Ponatinib—SRC—Immune System—FCGR2A—Kawasaki disease	0.000169	0.000494	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—CD4—Kawasaki disease	0.000168	0.000492	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—CD4—Kawasaki disease	0.000164	0.000481	CbGpPWpGaD
Ponatinib—SRC—Immune System—BLK—Kawasaki disease	0.000164	0.00048	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—CD4—Kawasaki disease	0.000161	0.000472	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—CD4—Kawasaki disease	0.000159	0.000466	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—CD4—Kawasaki disease	0.000159	0.000465	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—MMP9—Kawasaki disease	0.000157	0.00046	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—MMP9—Kawasaki disease	0.000156	0.000458	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD40—Kawasaki disease	0.000154	0.00045	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—CD4—Kawasaki disease	0.000153	0.000448	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—CD4—Kawasaki disease	0.000153	0.000447	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—CRP—Kawasaki disease	0.000151	0.000441	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—CCR5—Kawasaki disease	0.000149	0.000436	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CRP—Kawasaki disease	0.000147	0.000432	CbGpPWpGaD
Ponatinib—FGFR2—Disease—CCR5—Kawasaki disease	0.000146	0.000429	CbGpPWpGaD
Ponatinib—KIT—Immune System—CRP—Kawasaki disease	0.000145	0.000424	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—CD4—Kawasaki disease	0.000145	0.000424	CbGpPWpGaD
Ponatinib—KIT—Disease—CCR5—Kawasaki disease	0.000144	0.000421	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ITPKC—Kawasaki disease	0.000143	0.00042	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—VEGFA—Kawasaki disease	0.000141	0.000413	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—MMP9—Kawasaki disease	0.000141	0.000411	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—VEGFA—Kawasaki disease	0.00014	0.000411	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—CD4—Kawasaki disease	0.00014	0.00041	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—CD4—Kawasaki disease	0.00014	0.000409	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—MMP9—Kawasaki disease	0.000138	0.000405	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—MMP9—Kawasaki disease	0.000138	0.000403	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CRP—Kawasaki disease	0.000137	0.000402	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CRP—Kawasaki disease	0.000137	0.000401	CbGpPWpGaD
Ponatinib—FGFR1—Disease—CCR5—Kawasaki disease	0.000136	0.000399	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD40—Kawasaki disease	0.000136	0.000398	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—CCR5—Kawasaki disease	0.000136	0.000398	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—CD4—Kawasaki disease	0.000135	0.000394	CbGpPWpGaD
Ponatinib—FGFR3—Disease—CD4—Kawasaki disease	0.000134	0.000391	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CCR5—Kawasaki disease	0.00013	0.00038	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—VEGFA—Kawasaki disease	0.000126	0.00037	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—VEGFA—Kawasaki disease	0.000124	0.000363	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—VEGFA—Kawasaki disease	0.000124	0.000362	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—VEGFA—Kawasaki disease	0.000122	0.000356	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—VEGFA—Kawasaki disease	0.000121	0.000355	CbGpPWpGaD
Ponatinib—LYN—Immune System—CRP—Kawasaki disease	0.000121	0.000354	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CRP—Kawasaki disease	0.00012	0.000352	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—CD4—Kawasaki disease	0.000115	0.000336	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	0.000114	0.000334	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—CD4—Kawasaki disease	0.00011	0.000323	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—MMP9—Kawasaki disease	0.00011	0.000323	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CCR5—Kawasaki disease	0.000103	0.0003	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—CD4—Kawasaki disease	0.000102	0.000298	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CCR5—Kawasaki disease	0.000101	0.000295	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—MMP9—Kawasaki disease	0.0001	0.000294	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—VEGFA—Kawasaki disease	9.98e-05	0.000292	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CD4—Kawasaki disease	9.96e-05	0.000292	CbGpPWpGaD
Ponatinib—LCK—Immune System—CRP—Kawasaki disease	9.91e-05	0.00029	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—VEGFA—Kawasaki disease	9.9e-05	0.00029	CbGpPWpGaD
Ponatinib—LCK—Disease—CCR5—Kawasaki disease	9.84e-05	0.000288	CbGpPWpGaD
Ponatinib—KIT—Immune System—CD4—Kawasaki disease	9.78e-05	0.000286	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—CD4—Kawasaki disease	9.77e-05	0.000286	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CCR5—Kawasaki disease	9.56e-05	0.00028	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CCR5—Kawasaki disease	9.53e-05	0.000279	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CD4—Kawasaki disease	9.28e-05	0.000272	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CD4—Kawasaki disease	9.26e-05	0.000271	CbGpPWpGaD
Ponatinib—FGFR2—Disease—CD4—Kawasaki disease	9.2e-05	0.000269	CbGpPWpGaD
Ponatinib—KIT—Disease—CD4—Kawasaki disease	9.03e-05	0.000264	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—VEGFA—Kawasaki disease	9.01e-05	0.000264	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—VEGFA—Kawasaki disease	8.84e-05	0.000259	CbGpPWpGaD
Ponatinib—SRC—Immune System—CRP—Kawasaki disease	8.77e-05	0.000257	CbGpPWpGaD
Ponatinib—SRC—Disease—CCR5—Kawasaki disease	8.71e-05	0.000255	CbGpPWpGaD
Ponatinib—FGFR1—Disease—CD4—Kawasaki disease	8.57e-05	0.000251	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—CD4—Kawasaki disease	8.55e-05	0.00025	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CCR5—Kawasaki disease	8.41e-05	0.000246	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD4—Kawasaki disease	8.17e-05	0.000239	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—MMP9—Kawasaki disease	8.15e-05	0.000239	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD4—Kawasaki disease	8.13e-05	0.000238	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—VEGFA—Kawasaki disease	7.32e-05	0.000214	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—MMP9—Kawasaki disease	7.1e-05	0.000208	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CCR5—Kawasaki disease	6.89e-05	0.000202	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD4—Kawasaki disease	6.69e-05	0.000196	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—VEGFA—Kawasaki disease	6.38e-05	0.000187	CbGpPWpGaD
Ponatinib—LCK—Disease—CD4—Kawasaki disease	6.18e-05	0.000181	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCR5—Kawasaki disease	6.1e-05	0.000179	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD4—Kawasaki disease	5.93e-05	0.000173	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MMP9—Kawasaki disease	5.61e-05	0.000164	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MMP9—Kawasaki disease	5.51e-05	0.000161	CbGpPWpGaD
Ponatinib—SRC—Disease—CD4—Kawasaki disease	5.47e-05	0.00016	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MMP9—Kawasaki disease	5.23e-05	0.000153	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MMP9—Kawasaki disease	5.21e-05	0.000153	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—VEGFA—Kawasaki disease	5.04e-05	0.000147	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—VEGFA—Kawasaki disease	4.95e-05	0.000145	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—VEGFA—Kawasaki disease	4.69e-05	0.000137	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—VEGFA—Kawasaki disease	4.68e-05	0.000137	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MMP9—Kawasaki disease	4.6e-05	0.000135	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—VEGFA—Kawasaki disease	4.13e-05	0.000121	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MMP9—Kawasaki disease	3.77e-05	0.00011	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—VEGFA—Kawasaki disease	3.38e-05	9.91e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MMP9—Kawasaki disease	3.34e-05	9.77e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—VEGFA—Kawasaki disease	3e-05	8.77e-05	CbGpPWpGaD
